|
Volumn 60 Suppl B, Issue , 2005, Pages 52-56
|
Treatment of chronic hepatitis B in HIV co-infected patients.
|
Author keywords
[No Author keywords available]
|
Indexed keywords
LAMIVUDINE;
RNA DIRECTED DNA POLYMERASE INHIBITOR;
COMORBIDITY;
DISEASE COURSE;
HEPATITIS B;
HIGHLY ACTIVE ANTIRETROVIRAL THERAPY;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
PATHOPHYSIOLOGY;
RECURRENT DISEASE;
REVIEW;
RISK FACTOR;
ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE;
COMORBIDITY;
DISEASE PROGRESSION;
HEPATITIS B, CHRONIC;
HIV INFECTIONS;
HUMANS;
LAMIVUDINE;
RECURRENCE;
REVERSE TRANSCRIPTASE INHIBITORS;
RISK FACTORS;
|
EID: 26944502780
PISSN: 03005283
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
Times cited : (3)
|
References (26)
|